Regulatory Changes and Reimbursement Policies: Changes in Medicare or private insurance coverage and reimbursement rates for diagnostic tests directly impact Castle Biosciences' revenue and profitability, as evidenced by past Medicare coverage changes for DecisionDx-SCC.

Interest Rates and Economic Conditions: Higher interest rates can increase the cost of capital for a growth-oriented company like Castle Biosciences, impacting its ability to fund research, development, and commercial expansion. Broad economic slowdowns could also indirectly affect healthcare spending, even for covered diagnostic tests.

Competition and Technological Advancements in Molecular Diagnostics: The rapidly evolving field of molecular diagnostics means Castle Biosciences faces ongoing competition from existing players and new entrants. Continuous innovation and effective differentiation of its tests are crucial for maintaining market share and pricing power.